Zepto Life Technology is proud to announce the formation of a distinguished advisory board comprised of world-renowned experts in infectious diseases, cell-free DNA detection, molecular test development, and FDA regulatory expertise. This exceptional board will provide invaluable guidance and support, positioning Zepto Life Technology to drive forward its mission of improving diagnostic standards and advancing patient outcomes worldwide.
Gary Procop, MD, PhD
Chief Executive Officer, American Board of Pathology
Professor and Chair of Clinical Pathology, Cleveland Clinic
A world-renowned microbiologist, pathologist, and infectious disease specialist, Dr. Procop’s leadership and research continue to advance the field of clinical pathology.
Sean Zhang, MD, PhD
Associate Professor and Laboratory Director, Mycology Laboratory, Johns Hopkins
As a co-founding chair of the Fungal Diagnostics Laboratory Consortium (FDLC) and a leading expert in fungal infection diagnostics, Dr. Zhang’s work is pivotal in the field of mycology.
Bruce Klein, MD, PhD
Professor and Division Chief of Infectious Diseases, University of Wisconsin
Dr. Klein has over two decades of leadership in pediatrics and research focusing on Blastomyces dermatitidis and immunology, contributing significantly to our understanding of infectious diseases.
Gang Zheng, MD, PhD
Professor, Department of Laboratory Medicine and Pathology, Mayo Clinic
Dr. Zheng’s expertise in circulating cell-free DNA (cfDNA) and liquid biopsy cancer testing based on next-generation sequencing and epigenetic markers is crucial for advancing cancer diagnostics.
Ming Mai, MS
Principal Developer, Department of Laboratory Medicine and Pathology, Mayo Clinic
A molecular diagnostic and laboratory-developed test expert, Mr. Mai has over 20 years of experience with LDT and FDA-cleared tests, driving innovation in molecular diagnostics.